Salud | Kodawire Global Intelligence

Overlooked Therapy Revolutionizing Sickle Cell Care in Africa

Sickle cell disease affects 7.7 million worldwide, with over 75% of cases in Africa and 300,000 annual births in sub-Saharan Africa. Red blood cell exchange, an underutilized therapy, lowers sickle hemoglobin, prevents strokes, manages pain crises, and offers a repeatable alternative to bone marrow transplants without needing donors. Recent successful procedures highlight its potential to reduce hospitalizations and improve quality of life.

002

Overlooked Therapy Revolutionizing Sickle Cell Care in Africa

Sickle cell disease affects 7.7 million worldwide, with over 75% of cases in Africa and 300,000 annual births in sub-Saharan Africa. Red blood cell exchange, an underutilized therapy, lowers sickle hemoglobin, prevents strokes, manages pain crises, and offers a repeatable alternative to bone marrow transplants without needing donors. Recent successful procedures highlight its potential to reduce hospitalizations and improve quality of life.

003

Overlooked Therapy Revolutionizing Sickle Cell Care in Africa

Sickle cell disease affects 7.7 million worldwide, with over 75% of cases in Africa and 300,000 annual births in sub-Saharan Africa. Red blood cell exchange, an underutilized therapy, lowers sickle hemoglobin, prevents strokes, manages pain crises, and offers a repeatable alternative to bone marrow transplants without needing donors. Recent successful procedures highlight its potential to reduce hospitalizations and improve quality of life.